Sort
82,697 grants matching “vaccine development”
Center for Molecular, Cellular, and Translational Immunology
$1,177,361William R Green · Dartmouth College · P30 · FY2014 · GM
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
$1,177,164Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · U01 · FY2007 · AI
Science in a Culture of Mentoring
$1,177,136Judith A James · Oklahoma Medical Research Foundation · P30 · FY2011 · RR
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$1,177,109Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2022 · AI
Core A - Administrative Core
$1,176,995James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2025 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$1,176,834Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development
$1,176,799Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
DNA Vaccines
$1,176,511George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
New Strategies to Prevent Death from Influenza
$1,176,371Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · AI
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES
$1,176,222Rustom Noshir Antia · Emory University · U01 · FY2022 · AI
Viral Genomics: evolution, spread, and host interactions
$1,175,776Bruce W. Birren · Broad Institute, Inc. · U19 · FY2014 · AI
Characterization of immunogenic and structural properties of HIV-1 envelope
$1,175,614Michael W Cho · Case Western Reserve University · P01 · FY2008 · AI
Research to control and eliminate malaria in SE Asia and SW Pacific
$1,175,567James Walter Kazura · Case Western Reserve University · U19 · FY2012 · AI
Evaluation of Novel PE Malaria Vaccine Candidates
$1,175,442Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,175,233Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2009 · AI
Development of a Multi-species Vaccine for Prevention of Bacterial Otitis Media
$1,175,029Charles C. McOsker · Clarametyx Bioscience, Inc. · R44 · FY2024 · DC
21st International AIDS Conference (AIDS 2016), Durban, South Africa, 17-22 July 2016
$1,175,000Chris Beyrer · Ias · R13 · FY2016 · AI
Broad-spectrum, small-molecule inhibitors of bunyaviruses
$1,174,957Robert Douglas Allen · Siga Technologies, Inc. · U01 · FY2009 · AI
CEIRR: SARS-CoV-2 Research Activities
$1,174,838Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI
SBIR Phase II: Development of a Wireless pH Sensing Stir Bar
$1,174,656Kristian M Scaboo · Gate Scientific, Inc. · · FY2021 · TIP
Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND
$1,174,622Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2016 · AG
VACCINE TREATMENT AND EVALUATION UNIT:CONCEPT AND PROTOCOL DEVELOPMENT
$1,174,469Clarence Buddy Creech · Vanderbilt University · N01 · FY2018 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases
$1,174,464Corine Kruiswijk · Intravacc B.V. · N01 · FY2025 · AI
NORTH CAROLINA STD COOPERATIVE RESEARCH CENTER
$1,174,414University Of North Carolina Chapel Hill · U19 · FY2001 · AI
A Nurse-Community Health Worker-Family Partnership Model to Increase COVID-19 Testing in Urban Underserved and Vulnerable Communities
$1,174,281Don C Des Jarlais · New York University · P30 · FY2022 · DA